Evidence map›Paper›PMID 26291516›Full record

ArticleGenes and immunity2015

Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes.

F W Miller, W Chen, T P O'Hanlon, R G Cooper, J Vencovsky, L G Rider, K Danko, L R Wedderburn, I E Lundberg, L M Pachman and 16 more

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Genes and immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 78 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 3 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00017914 recruitingnot on this map

Studies in the Natural History and Pathogenesis of Childhood-Onset and Adult-Onset Idiopathic Inflammatory Myopathies

TypeobservationalSponsorNational Institute of Environmental Health Sciences (NIEHS)Ran1995Enrolled1,200ConditionsDermatomyositis, Polymyositis, Inclusion Body Myositis
NCT00341679 completednot on this map

Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases

TypeobservationalSponsorNational Institute of Environmental Health Sciences (NIEHS)Ran2005Enrolled719ConditionsAutoimmune/Connective Tissue Diseases, Idiopathic Inflammatory Myopathies, Polymyositis, Dermatomyositis
3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 3 syntheses or guidelines pooled it, 132 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Genome-wide meta-analysis reveals shared newAnnals of the rheumatic diseases · 2019
    Pooled it
  4. Review
  5. Article
  6. Review
  7. Article
  8. Association betweenFrontiers in immunology · 2026
    Article
  9. HLA-AJournal of immunology research · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 17 institutions in 7 countries.

F W MillerNational Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, USA.
W ChenM.D. Anderson Cancer Center, Houston, TX, USA.
T P O'HanlonNational Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, USA.
R G CooperMRC/ARUK Institute for Ageing and Chronic Disease, University of Liverpool, UK.
J VencovskyInstitute of Rheumatology, Charles University, Prague, Czech Republic.
L G RiderNational Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, USA.
K Danko3rd Department of Internal Medicine, Division of Immunology University of Debrecen, Debrecen, Hungary.
L R WedderburnInstitute of Child Health, University College London, London, UK.
I E LundbergRheumatology Unit, Department of Medicine, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden.
L M PachmanDepartment of Pediatric Rheumatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
A M ReedMayo Clinic, Rochester, MN, USA.
S R YtterbergMayo Clinic, Rochester, MN, USA.
L PadyukovRheumatology Unit, Department of Medicine, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden.
A Selva-O'CallaghanVall d'Hebron General Hospital, Barcelona, Spain.
T R RadstakeDepartment of Rheumatology and Clinical Immunology, Laboratory for Translational Immunology, Utrecht University Medical Center; and Nijmegen Center for Molecular Life Sciences, Nijmegen, The Netherlands.
D A IsenbergDivision of Medicine, University College London, London, UK.
H ChinoyThe National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit, Centre for Musculoskeletal Research, University of Manchester, Manchester, UK.
W E R OllierCentre for Integrated Genomic Medical Research, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
P ScheetM.D. Anderson Cancer Center, Houston, TX, USA.
B PengM.D. Anderson Cancer Center, Houston, TX, USA.
A LeeRobert S. Boas Center for Genomics and Human Genetics, Feinstein Institute for Medical Research, Manhasset, NY, USA.
J ByunDepartment of Community and Family Medicine, Dartmouth College, Hanover, NH, USA.
J A LambCentre for Integrated Genomic Medical Research, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
P K GregersenRobert S. Boas Center for Genomics and Human Genetics, Feinstein Institute for Medical Research, Manhasset, NY, USA.
C I AmosDepartment of Community and Family Medicine, Dartmouth College, Hanover, NH, USA.
Myositis Genetics Consortium
The University of Texas MD Anderson Cancer Center · USDartmouth College · USFeinstein Institute for Medical Research · USManchester Academic Health Science Centre · GBMayo Clinic in Arizona · USNational Institutes of Health · USUniversity College London · GBCharles University · CZKarolinska Institutet · SEKarolinska University Hospital · SENational Institute of Environmental Health Sciences · USNorthwestern University · USUniversity of Debrecen · HUUniversity of Liverpool · GBUniversity of Manchester · GBUtrecht University · NLVall d'Hebron Hospital Universitari · ES

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Steven D Leach · 1985 to 2026
$91.3M
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune DiseaseZIAES101074 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI RIDER, LISA · 2009 to 2025
$34.6M
Assessment, Therapy and Prevention Of Autoimmune DiseaseZIAES101081 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI RIDER, LISA · 2009 to 2025
$17.6M
Pathogenesis And Genetic/environmental Risk Factors ForZ01ES101074 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI MILLER, FREDERICK · 2002 to 2008
$2.7M
The Role of IL-17 Axis in Inflammatory MyositisR01AR057781 · NIAMS · MAYO CLINIC ROCHESTER · PI NIEWOLD, TIMOTHY B, PETERSON, ERIK J · 2010 to 2014
$1.6M
Intramural NIH HHS Z01 ES101074Medical Research Council MR/K006312/1NCI NIH HHS P30 CA016672NCI NIH HHS P30 CA023108NIEHS NIH HHS Z01ES101074Versus Arthritis 18474Wellcome Trust
6 · The paper itself

Abstract

Autoimmune muscle diseases (myositis) comprise a group of complex phenotypes influenced by genetic and environmental factors. To identify genetic risk factors in patients of European ancestry, we conducted a genome-wide association study (GWAS) of the major myositis phenotypes in a total of 1710 cases, which included 705 adult dermatomyositis, 473 juvenile dermatomyositis, 532 polymyositis and 202 adult dermatomyositis, juvenile dermatomyositis or polymyositis patients with anti-histidyl-tRNA synthetase (anti-Jo-1) autoantibodies, and compared them with 4724 controls. Single-nucleotide polymorphisms showing strong associations (P<5×10(-8)) in GWAS were identified in the major histocompatibility complex (MHC) region for all myositis phenotypes together, as well as for the four clinical and autoantibody phenotypes studied separately. Imputation and regression analyses found that alleles comprising the human leukocyte antigen (HLA) 8.1 ancestral haplotype (AH8.1) defined essentially all the genetic risk in the phenotypes studied. Although the HLA DRB1*03:01 allele showed slightly stronger associations with adult and juvenile dermatomyositis, and HLA B*08:01 with polymyositis and anti-Jo-1 autoantibody-positive myositis, multiple alleles of AH8.1 were required for the full risk effects. Our findings establish that alleles of the AH8.1 comprise the primary genetic risk factors associated with the major myositis phenotypes in geographically diverse Caucasian populations.

Indexed as

AllelesAdolescentAdultAutoantibodiesCase-Control StudiesDermatomyositisFemaleGenetic Association StudiesGenetic Predisposition to DiseaseGenome-Wide Association StudyHaplotypesHLA AntigensHumansMaleMiddle AgedMyositisAutoantibodiesHLA Antigens

Identifiers

PMID26291516
PMCPMC4840953
OpenAlexW2400303083

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.